API reference

Gemfibrozil

CAS number
25812-30-0
Molecular formula
C15H22O3
Molecular weight
250.33 g/mol
Gemfibrozil — 2D structure
2D structure (PubChem)

About this molecule

Gemfibrozil is a fibric acid derivative with hypolipidemic effects. Gemfibrozil interacts with peroxisome proliferator-activated receptors (PPARalpha) resulting in PPARalpha-mediated stimulation of fatty acid oxidation and an increase in lipoprotein lipase (LPL) synthesis. This enhances triglyceride-rich lipoprotein clearance and reduces the expression of apolipoprotein C-III (apoC-III). The reduction in hepatic production of apoC-III results in subsequent reduction of serum levels of very-low-density-lipoprotein cholesterol (VLDL-C). In addition, gemfibrozil-mediated PPARalpha stimulation of apoA-I and apoA-II expression results in an increase in high-density lipoprotein cholesterol (HDL-C).

Source: NCI Thesaurus (NCIt), via PubChem.

Identifiers

IUPAC name
5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid
InChIKey
HEMJJKBWTPKOJG-UHFFFAOYSA-N
SMILES
CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
Other CAS numbers recorded
114413-98-8
PubChem CID
3463

Also known as

gemfibrozil · 5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid · Lopid · Lipur · Jezil · Gemfibrozilo · Gemfibrozilum · Gemlipid

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com